How many investments has Selvedge Venture made?

Selvedge Venture has 12 tracked investments, including 1 dated in the last 24 months.

What stage does Selvedge Venture invest at?

Selvedge Venture invests at the Pre-Seed, Seed, Series A stages.

Where is Selvedge Venture located?

Selvedge Venture is headquartered in London, GB.

Who does Selvedge Venture co-invest with?

Selvedge Venture most often shares deals with Bantam Group, Flagship Pioneering, FoundersX Ventures, among 12 tracked co-investors.

Selvedge Venture

Venture capital

London · Pre-Seed–Series A · 3 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Selvedge Venture

975 people in our graph share verified history with the Selvedge Venture team — schools, employers, funds. One of them is your warm intro.

André Duboisunlockedknows Alasdair Thong · together at Index Ventures (overlapped)

×10knows the team · via Index Ventures

knows the team · via Eton College

✨ Fox Verdict

Investment thesis

Selvedge Venture invests in early-stage companies addressing age-related medical conditions, which it notes account for over 60% of human deaths. It concentrates on three areas: metabolic syndrome (including cardiovascular disease, diabetes, fatty liver disease and obesity), cancer, and neurodegenerative diseases, citing their large share of excess mortality and healthcare spending. The firm's core expertise sits at the intersection of biotechnology and digital technologies, leveraging advances in biotech, machine learning tools and integrated data assets to shape healthcare and life sciences. It backs pre-seed, seed and Series A-ready companies.

Invests inAI & Machine Learning Biotech Deep Tech Digital Health Healthtech Impact & Social Good Longevity Medical Devices Europe London Middle East & North Africa United States

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

London, GB

Instruments

Equity

Founded

2021

Tracked investments

Team · 3 people

from the firm's website

Alasdair Thong· Partner· Londonin 𝕏

Alasdair Thong is an investor at Ada Ventures, a pre-seed venture firm, where his work centers on the firm's software and tooling efforts and its AI investment thesis. He helped build a beta version of AdaGPT, a pitch deck feedback app used by over 200 founders per month. His writing develops Ada's "inclusive alpha" approach to backing AI-first companies at the application and applied infrastructure layers, and he has been active in shaping the firm's framework for investing in generative AI. He was among the developers who gained early access to GPT-3 in 2020.

Robert Thong· Venture Partner· Londonin 𝕏

Robert Thong has more than 30 years of experience in biopharma and healthcare, having worked with over 100 organizations across 14 countries. His career includes co-heading the Life Sciences Group at Capgemini, leading the Bioscience team at COBA, serving as Managing Director of Datamonitor Healthcare, and founding three boutique bioscience consultancies. He holds a BSc in Mathematics from Imperial College London and an MBA from MIT, qualified as an actuary, and now focuses on SMEs and startups in areas such as bioinformatics, precision medicine, therapeutics discovery, and cell and gene therapy.

Esra Berkol· Investor Relations (US and Middle East markets)· Istanbul, Türkiyein

Esra Berkol joined Selvedge Venture in August 2020 as part of the founding team, leading investor relations with a focus on the US and Middle East markets. Before this, she founded and later exited Craft Ktchn, a Turkey-based restaurant, delivery, and catering group she started in 2016. Earlier in her career she worked at Foreks, a financial data and solutions provider in Istanbul, in business development and product management, and helped establish a joint venture between Foreks and Montel. She holds a BA in Economics and Political Science from Tufts University and completed corporate finance courses at the Fletcher School of Law and Diplomacy.

Founder mafia

3 people who came through Selvedge Venture went on to found or lead other companies.

Alasdair ThongPartnerFounded Ada Ventures +1 Robert ThongVenture PartnerFounded Multiomic Health Oliver ArmitageTechnology FellowFounded BIOS Health

What they invest in

from 12 of 12 portfolio companies

Biotech ×9Healthtech ×5AI & Machine Learning ×4Deep Tech ×4EdTech ×4Medical Devices ×4Impact & Social Good ×3Digital Health ×2

HQs:United Kingdom×5United States×5Denmark×1

Investments · showing 10 of 12

founders shown can be your intro path

By year:2023 · 1 2022 · 12 dated

BIOS Healthbios.health in 𝕏Jun 2023

BIOS develops neural digital therapy technology to deliver treatments for neurological conditions.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Oliver Armitage(Founder)in Emil Hewage(Founder/Director)in

Co-investorsFifty Years Heuristic Capital Partners Kern Venture Group The Venture Collective Y Combinator

Bob Langermit.edu 𝕏

MIT is an educational and research institution in Cambridge, Massachusetts, pursuing teaching, research, and innovation across science, engineering, and other fields.

BiotechEdTechCambridge, US

Co-investorsBeyond Earth Ventures Flagship Pioneering FoundersX Ventures JIMCO Lair East Labs MassChallenge Mexico

Carbometricscarbometrics.com in

Carbometrics is developing i-CAM, a continuous metabolic monitor for cardiopulmonary bypass and organ perfusion circuits used in medical procedures.

HardwareHealthtechMedical Devices

Co-investorsAda Ventures Science Creates Ventures

Exogeneexogene.co.ukApr 2022

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Federico Paoletti(CEO & Co-Founder)in Andrea Mambrini(CTO & Co-Founder)in

Co-investorsEntrepreneur First Unruly Capital R42 Group

Kytopenkytopen.com in

Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.

BiotechDeep TechHardwareCambridge, US

Cullen Buie(Director)in Paulo Garcia(Executive Officer, Director, Promoter)inMichael Chiu(Director, Executive Officer)in

Board Paxton Major(Director)in Ann DeWitt(Director)inPaul Wotton(Director)

Co-investorsBantam Group Horizons Ventures MassVentures TBD Angels Telegraph Hill Partners The Engine Ventures +2 more

Labcentrallabcentral.org in 𝕏

LabCentral is an incubator and shared laboratory facility for early-stage life science startups, offering wet lab space, core facilities, business support programs, and a network of scientific and entrepreneurial resources.

BiotechDeep TechImpact & Social GoodCambridge, US

Nsfnsf.gov in 𝕏

The U.S.

AI & Machine LearningDeep TechEdTechGovTechImpact & Social GoodArlington, US

Ochre Bioochre-bio.com in 𝕏

Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.

AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB

Quin Wills(Founder/CSO)in Jack O'Meara(Founding CEO)in

BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle

Co-investorsBacked Beast Ventures CoastCap Entrepreneur First Expa Hoxton Ventures +6 more

Rscrsc.org in

The Royal Society of Chemistry is a professional membership organisation that connects the global chemistry community through partnerships, conferences, networks and publications.

BiotechClimate TechEdTechEnergyImpact & Social GoodMedia & EntertainmentLondon, GB

Thomas Graham(First President)

Wileywiley.com in 𝕏

Wiley is a publishing and digital solutions company that provides content, tools, and services to academic institutions, research libraries, government agencies, healthcare systems, and journal publishers.

Data & InfrastructureEdTechEnterprise SoftwareMedia & Entertainment

Portfolio news

latest coverage across their companies

John Wiley & Sons (WLYB) versus Its Rivals Financial Review - Ticker Report

Wiley · tickerreport.com · Aug 23, 2026

Kytopen Raises Series B to Scale Cell Therapy Manufacturing Platform - Cambridge Today

Kytopen · nationaltoday.com · Apr 10, 2026

Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology

Bob Langer · businesswire.com · Nov 6, 2025

After building Ochre Bio, Jack O'Meara's newest biotech raises $21M for neuro siRNAs

Ochre Bio · endpoints.news · Oct 1, 2025

Principals & officers · per Companies House

what is this? ⓘ

Alasdair Robert Thong

Director · British · since 2021

Robert Vee-Lin Thong

Director · British · since 2021

Ownership & control

Robert Thong — 25–50% of shares, 25–50% of voting rights

Alasdair Robert Thong — 25–50% of shares, 25–50% of voting rights

Selvedge Innovation Llp — 75–100% of shares, 75–100% of voting rights

Frequently asked questions

How many investments has Selvedge Venture made?: Selvedge Venture has 12 tracked investments, including 1 dated in the last 24 months.
What stage does Selvedge Venture invest at?: Selvedge Venture invests at the Pre-Seed, Seed, Series A stages.
What sectors does Selvedge Venture focus on?: Selvedge Venture focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices.
Where is Selvedge Venture located?: Selvedge Venture is headquartered in London, GB.
Who does Selvedge Venture co-invest with?: Selvedge Venture most often shares deals with Bantam Group, Flagship Pioneering, FoundersX Ventures, among 12 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Project Astra | Exploring the Capabilities of a Universal AI Assistant

Google · Alasdair Thong

Images

Co-investors · 2

Ada Ventures

Ada Ventures is a venture capital firm that backs early-stage founders, offering support such as back-up childcare, founder welfare resources, a growth specialist for sales and go-to-market, and a dedicated talent partner to help build teams.

Both backed · 1

Carbometrics

$317.5K – $1.3M

Cambridge Angels group

Cambridge Angels is a UK business angel network that has been providing capital and operational support to entrepreneurs since 2001, backing more than 150 companies.

$195K – $1.9M

Firms observed investing alongside Selvedge Venture, from public investor directories. Shared companies are the overlap with Selvedge Venture's recorded portfolio.

Similar investors

Future Positive Capital

Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.

$250K

Sofinnova Partners

Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.

$540K – $27M

CABHI Ventures

CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.